American College of Radiology (ACR)

The American College of Radiology represents diagnostic radiologists, radiation oncologists, interventional radiologists, nuclear medicine physicians and medical physicists. The society represents more than 41,000 diagnostic and interventional radiologists, radiation oncologists, nuclear medicine physicians and medical physicists. ACR helps members, through advocacy, quality and safety, and innovation, and serves as the voice of radiology, demonstrating value and setting standards to advance the field and practice.

RSS icon
Thumbnail

VIDEO: Where are we with AI adoption in radiology?

Bibb Allen, MD, FACR, chief medical officer of the American College of Radiology (ACR) Data Science Institute, discusses multiple factors involved in the adoption rate of artificial intelligence in radiology.
 

Ischemic stroke shown in CT scans. Image courtesy of RSNA

VIDEO: AI for stroke detection on CT imaging

Bibb Allen, MD, FACR, chief medical officer of the American College of Radiology (ACR) Data Science Institute, explains the trend of using AI for the automated detection of stroke on computed tomography (CT) imaging and the need to include radiologists on the stroke care team.

Thumbnail

Concerns raised over how hospitals can validate radiology AI algorithms

As artificial intelligence (AI) adoption expands in radiology, there is growing concern that AI algorithms need to undergo quality assurance (QA) reviews.

Bibb Allen, MD, FACR, chief medical officer of the American College of Radiology (ACR) Data Science Institute, and former ACR president, explains how hospitals or radiology departments can conduct quality assurance (QA) assessments on artificial intelligence (AI) algorithms they adopt to ensure they are accurate. The ACR established the Assess-AI Registry and AI-Lab to help with validating and tracking AI QA for FDA-cleared algorithms.

VIDEO: Validation monitoring for radiology AI to ensure accuracy

Bibb Allen, MD, FACR, Chief Medical Officer of the American College of Radiology (ACR) Data Science Institute, and former ACR president, explains how hospitals or radiology departments can conduct quality assurance assessments on artificial intelligence algorithms they adopt to ensure they are accurate. 

An overview of artificial intelligence (AI) in radiology with Keith Dreyer with the ACR. Images shows a COVID-19 lung CT scan reconstruction from Siemens Healthineers. #AI #radAI #ACR

VIDEO: Overview of radiology AI by Keith Dreyer

Keith J. Dreyer, DO, PhD, FACR, American College of Radiology (ACR) Data Science Institute Chief Science Officer, explains the state of AI in radiology in 2022. 

Example of an artificial intelligence (AI) app store on the Sectra website, where Sectra PACS users can select the AI algorithms they want that are already integrated into the Sectra System. Other vendors have followed a similar approach to AI developed by many smaller vendors they partner with.

VIDEO: Development of AI app stores to enable easier access

Keith J. Dreyer, DO, PhD, FACR, American College of Radiology (ACR) Data Science Institute Chief Science Officer, explains how radiology vendors have developed AI app stores to make it easier to access new FDA cleared AI algorithms.
 

Keith J. Dreyer, DO, PhD, FACR, American College of Radiology (ACR) Data Science Institute Chief Science Officer, explains artificial intelligence (AI) for radiology. Dreyer also holds the positions of vice chairman of radiology at Massachusetts General Hospital, chief data science and information officer for the departments of radiology for both Massachusetts General Hospital and Brigham and Women's Hospital.

VIDEO: Where will radiology AI be in 5 years?

Keith J. Dreyer, DO, PhD, FACR, American College of Radiology (ACR) Data Science Institute Chief Science Officer, explains 5 developments to watch for in radiology artificial intelligence (AI).

Thumbnail

Cardiologists, radiologists join American Medical Association to speak out against ACA lawsuit

Yet another lawsuit is taking aim at the Affordable Care Act, and 61 U.S. medical organizations have joined forces to speak out.

Displaying 9 - 16 of 23

Around the web

Cardiovascular Business
FDA says years-long tirzepatide shortage is resolved, will give limited leeway to compounders

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

AI in Healthcare
From Capitol Hill to a hospital near you? 5 federal recommendations for healthcare AI policy

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Cardiovascular Business
Merck spends up to $2B to license new weight loss drug with potential heart benefits

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.